mRNA therapeutics

Explore our latest white paper examining how advanced formulation science, particle engineering, and device integration can overcome the structural fragility of macromolecules. Discover how ABINITIO builds the protective delivery architecture required to reliably translate complex peptides, proteins, and RNA therapeutics into successful clinical outcomes.

Publications

Preclinical tools for early phase formulation development

Read our article on how upper respiratory in vitro models can be used to strengthen IVIVC and improve confidence in nasal and inhaled drug development before clinical studies.

Publications

Developing oligonucleotide therapies for lung delivery

Read our article on how nebulised oligonucleotide formulations can be developed and evaluated to supporteffective pulmonary delivery for chronic respiratory disease.

Sign up to The Power of Three, our newsletter which provides weekly insights on the the ins and outs of the drug development process.

Submit